Severe acute respiratory syndrome

Electronic Skin Patches Sales to Reach USD 29 Billion by 2027, Next-Gen Electronic Skin Patches to Witness Tremendous Demand. Abbott, Dexcom, GE, and Philips Set to Capatilize the Opportunity - Arizton

Retrieved on: 
Wednesday, December 14, 2022
Escherichia coli, Chemistry, HIV, West Nile virus, Dengue fever, Skin, Infection, Patient, Radiation, Zika virus, Pandemic, Tuberculosis, Epidemic, Orthohantavirus, Science and technology in Asia, Health care, Lyme disease, COVID-19, WHO, UV, Severe acute respiratory syndrome, Cosmetics, Vaccine, Zika fever

A Rise in the Usage of Electronic Skin Patches for Drug Delivery & Cosmetics.

Key Points: 
  • A Rise in the Usage of Electronic Skin Patches for Drug Delivery & Cosmetics.
  • The emergence of electronic skin patches has been widely helpful in managing an individual's health either on their own or in any healthcare setting.
  • To manage patients suffering from various infectious diseases, significant advancements are likely to happen in electronic skin patches.
  • Electronic skin patches are used as cosmetic delivery systems for providing active ingredients that help maintain the ideal nature of the skin.

Deswell Announces First Half 2023 Results

Retrieved on: 
Friday, November 18, 2022
Manufacturing, Machinery, Engineering, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics, Severe acute respiratory syndrome, Natural borrowing limit, Security (finance), Electronics, Computer Peripherals, Plastic, Growth, Travel, Website, Renewable energy, Cassette tape, Bank, Manufacturing, Machinery, Engineering, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics

Deswell Industries, Inc. (Nasdaq: DSWL) today announced its unaudited financial results for the first six months of fiscal 2022, ended September 30, 2022.

Key Points: 
  • Deswell Industries, Inc. (Nasdaq: DSWL) today announced its unaudited financial results for the first six months of fiscal 2022, ended September 30, 2022.
  • Gross profit margin in the plastic segment increased to 13.2% of net sales for the first half of fiscal 2022, compared to 10.7% of net sales for the corresponding period of last fiscal year.
  • Operating income in the first half of fiscal 2023 was $2.0 million, compared to operating income of $1.2 million for the same period of fiscal 2022.
  • Deswell undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in Deswells expectations.

Eco HealthTech Apparel Brand Swiss Precision Launches StartEngine Crowdfunding Campaign

Retrieved on: 
Thursday, November 3, 2022
Textiles, Medical Supplies, Infectious Diseases, Hospitals, Professional Services, Manufacturing, Health, General Health, Crowdfunding, Virus, Workplace, Research, Transport, Hospital, Multimedia, SARS, Better Business Bureau, Association of British HealthTech Industries, Mask, Industry, Nursing, Severe acute respiratory syndrome, Joint Commission, Safety, Swiss Precision Diagnostics, Copper, Joint, CEO, Airport, AMP, School, MERS, Chief Dental Officer (United Kingdom), Technology, Eye, Original equipment manufacturer, Patient, Solution, Amazon, Activision, Fabrique

Swiss Precision , an Eco HealthTech apparel brand for the medical scrub, uniform, and accessories markets, announced the launch of their StartEngine Crowdfunding campaign today.

Key Points: 
  • Swiss Precision , an Eco HealthTech apparel brand for the medical scrub, uniform, and accessories markets, announced the launch of their StartEngine Crowdfunding campaign today.
  • Swiss Precision has found its unique niche by creating an innovative product that elevates, refreshes, and disrupts the ages-old medical scrub and uniform industry.
  • With the extra protection and style Eco HealthTech apparel has to offer, it is the perfect collaboration for branding and for AMP Staffing Networks vision.
  • Swiss Precision is an Eco HealthTech apparel brand, blending copper and natural organic fabrics for the medical scrub, uniform, and accessories markets.

Darling Ingredients Inc. Announces Closing of Private Offering of $250.0 Million of Unsecured Senior Notes due 2030.

Retrieved on: 
Wednesday, August 17, 2022
Epidemic, U.S. Securities and Exchange Commission, Securities Act of 1933, DAR, Union, Poultry, Food, United Kingdom, Industry, Influenza A virus subtype H1N1, NYSE, Legislation, African swine fever virus, SARS, Failure, Sale, ASF, LLC, Security (finance), Plant, Grain, Meat, SEC Rule 144A, Cattle, Government, Disease, Compliance, COVID-19, Company, Bovine spongiform encephalopathy, DE, Pandemic, Bird Flu, Natural gas, BSE, Collagen, Severe acute respiratory syndrome, Software, Private Securities Litigation Reform Act, Regulation, Meal, Biofuel, PED, Person, Renewable energy

IRVING, Texas, Aug. 17, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the closing of its private offering of $250.0 million aggregate principal amount of its unsecured senior notes due 2030 (the "add-on notes").

Key Points: 
  • IRVING, Texas, Aug. 17, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the closing of its private offering of $250.0 million aggregate principal amount of its unsecured senior notes due 2030 (the "add-on notes").
  • The add-on notes bear interest at 6% per annum, payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2022.
  • Interest on the add-on notes will accrue from, and including, June 9, 2022, the first day of the current interest period for the initial notes.
  • Darling Ingredients Inc. (NYSE: DAR) is the largest publicly traded company turning food waste into sustainable products and a leading producer of renewable energy.

Darling Ingredients Inc. Announces Pricing of Private Offering of $250.0 Million of Unsecured Senior Notes due 2030

Retrieved on: 
Monday, August 15, 2022
Epidemic, U.S. Securities and Exchange Commission, Securities Act of 1933, DAR, Union, Poultry, Food, United Kingdom, Industry, Influenza A virus subtype H1N1, NYSE, Legislation, African swine fever virus, SARS, Failure, Sale, ASF, Security (finance), Plant, Grain, Meat, Compliance, SEC Rule 144A, Cattle, Government, Disease, COVID-19, Company, Bovine spongiform encephalopathy, Pandemic, Bird Flu, Natural gas, BSE, Collagen, Severe acute respiratory syndrome, Software, Private Securities Litigation Reform Act, Regulation, Meal, Biofuel, PED, Person, Renewable energy

IRVING, Texas, Aug. 15, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the pricing of its private offering of $250.0 million aggregate principal amount of its 6% unsecured senior notes due 2030 (the "add-on notes").

Key Points: 
  • IRVING, Texas, Aug. 15, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the pricing of its private offering of $250.0 million aggregate principal amount of its 6% unsecured senior notes due 2030 (the "add-on notes").
  • The add-on notes will be issued as additional notes under the same indenture (the "indenture") as Darling's 6% senior notes due 2030, $750.0 million in aggregate principal amount of which were issued on June 9, 2022 (the "initial notes").
  • The initial offering price to investors will be 102.0% of the principal amount thereof.
  • The offering is expected to close on or about August 17, 2022, subject to satisfaction of customary closing conditions.

Darling Ingredients Inc. Announces Private Offering of $250.0 Million of Unsecured Senior Notes

Retrieved on: 
Monday, August 15, 2022
Epidemic, U.S. Securities and Exchange Commission, Securities Act of 1933, DAR, Union, Poultry, Multimedia, Food, United Kingdom, Industry, Influenza A virus subtype H1N1, NYSE, Legislation, SARS, Failure, Sale, ASF, LLC, Security (finance), Plant, Grain, Meat, Credit, Credit agreements in South Africa, Cattle, Government, Disease, Compliance, COVID-19, Company, Bovine spongiform encephalopathy, View, DE, Pandemic, Bird Flu, Natural gas, BSE, Collagen, Severe acute respiratory syndrome, Software, Private Securities Litigation Reform Act, Regulation, Meal, PED, Person

IRVING, Texas, Aug. 15, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the launch of an offering of $250.0 million in aggregate principal amount of unsecured senior notes (the "add-notes") by Darling.

Key Points: 
  • IRVING, Texas, Aug. 15, 2022 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced the launch of an offering of $250.0 million in aggregate principal amount of unsecured senior notes (the "add-notes") by Darling.
  • The add-on notes will be issued as additional notes under the same indenture (the "indenture") as Darling's 6% senior notes due 2030, $750.0 million in aggregate principal amount of which were issued on June 9, 2022 (the "initial notes").
  • The guarantors of the add-on notes are the same guarantors as for the initial notes and Darling's existing dollar-denominated notes.
  • Darling Ingredients Inc. (NYSE: DAR) is the largest publicly traded company turning food waste into sustainable products and a leading producer of renewable energy.

Business Continuity Management & Scenario Planning - 2 Day Virtual Recorded Training Course - ResearchAndMarkets.com

Retrieved on: 
Monday, July 25, 2022
Education, Training, Professional Services, Business, SARS, COVID-19, Severe acute respiratory syndrome, Lists of disasters, Business continuity planning, Headache, Maintenance, Terrorism, Basel Committee on Banking Supervision, Risk, Risk management, Coronavirus, Weather, Organization, Responses to the West African Ebola virus epidemic, March 2021 Miyagi earthquake, Operational risk, DRP, Security (finance), Bank, Insurance

A 2-day intensive course on Business Continuity and Scenario Planning with a view to providing Professionals with a firm foundation of the standards of best practice in the critical area Business Continuity Planning.

Key Points: 
  • A 2-day intensive course on Business Continuity and Scenario Planning with a view to providing Professionals with a firm foundation of the standards of best practice in the critical area Business Continuity Planning.
  • One of the most crucial objectives of management is to learn how to deal with the new requirements with regard to Business Continuity Planning.
  • The course includes 3 detailed business continuity case studies and an interactive section on developing effective scenarios.
  • Effective Business Continuity Management - We explore the details of a range of activities aimed at identifying, controlling, and mitigating risks.

Eco HealthTech Apparel Brand Swiss Precision Launches

Retrieved on: 
Wednesday, July 20, 2022
Textiles, Women, Hospitals, Manufacturing, Other Health, Fashion, Health, Consumer, Retail, SARS, Virus, Original equipment manufacturer, Eyeish, AMP, Copper, Eye, Joint Commission, Industry, Hospital, SGS, CEO, Research, Severe acute respiratory syndrome, Culture, Solution, MERS, Better Business Bureau, Transport, Mask, Nursing, Safety, Multimedia, HAI, Facebook, Subclinical infection, Technology, Patient, Swiss Precision Diagnostics, Infection, Coronavirus, Wool, Fabrique, Amazon

Swiss Precision , an Eco HealthTech apparel brand for the medical scrub, uniform, and accessories markets, officially launched today with its mission of disrupting the medical scrub, uniform & accessories markets with unique copper + natural patented materials that kill or slow the spread of microorganisms.

Key Points: 
  • Swiss Precision , an Eco HealthTech apparel brand for the medical scrub, uniform, and accessories markets, officially launched today with its mission of disrupting the medical scrub, uniform & accessories markets with unique copper + natural patented materials that kill or slow the spread of microorganisms.
  • View the full release here: https://www.businesswire.com/news/home/20220720005744/en/
    Swiss Precision is an Eco HealthTech apparel brand, blending copper and natural organic fabrics for the medical scrub, uniform, and accessories markets.
  • Therefore, Eco HealthTech Apparel Brand Swiss Precision has partnered up with us to be a distributor of their apparel to our nurses and the community.
  • Swiss Precision is an Eco HealthTech apparel brand, blending copper and natural organic fabrics for the medical scrub, uniform, and accessories markets.

Animal Disinfectant Market Size to grow by USD 1.17 Million |Asia to Occupy 42% Market Share | Technavio

Retrieved on: 
Friday, July 1, 2022
Water, Feces, FIFRA, Adoption, Livestock, Growth, Urine, Blood, Analysis, Fluid mechanics, Mortality, Severe acute respiratory syndrome, Prevalence, Virulent Newcastle disease, Infection, FMD, Disclosure, Risk, Certification, CAGR, Environment, ISO, Saliva, PRRS, East Coast fever, Human, Animal, Disinfectant, Farmer, African swine fever virus, Safety, ISO 9001:2015, Sample, ROW, Brucellosis, Sewage, Vaccine, Bottled water, Geography, EU

The increasing prevalence of infectious diseases in animals willfacilitate theanimal disinfectant market growth in Asia over the forecast period

Key Points: 
  • The increasing prevalence of infectious diseases in animals willfacilitate theanimal disinfectant market growth in Asia over the forecast period
    The animal disinfectant market report is segmented by Type (liquid animal disinfectant and powdered animal disinfectant) and Geography (Europe, North America, Asia, and ROW).
  • Revenue generating segment:The animal disinfectant market share growth in theLiquid animal disinfectant segment will be significant for revenue generation.Liquid animal disinfectants are offered with the premixed dilution of concentrates (active ingredients) in the solvent (usually water).
  • An increasing prevalence of infectious diseases in animals is one of the key factors driving the growth of the global animal disinfectant market.
  • The animal disinfectant market is fragmented and the vendorsare deploying organic and inorganic growth strategiesto compete in the market.

Global Syndromic Multiplex Diagnostic Market Report (2022 to 2027) - Increasing Demand for Accurate and Rapid Results is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, June 17, 2022
Health, Biotechnology, Government, Patient, Laboratory, D, Awareness, Severe acute respiratory syndrome, Adoption, Hospital, USFDA, Infection, Pharmaceutical industry

Respiratory syndromes account for the largest share of the syndromic multiplex diagnostics market and expected to continue the same throughout the forecast period.

Key Points: 
  • Respiratory syndromes account for the largest share of the syndromic multiplex diagnostics market and expected to continue the same throughout the forecast period.
  • This dominance mainly due to factors such as the higher demand due to the rapid spread of infections along with the launch of new products with USFDA approvals in the segment that contributes to its major revenue share in the global market.
  • By End-user, hospitals account for the largest share due to the availability of all resources at a single facility.
  • North America has been the primary market for the syndromic multiplex diagnostic market and is expected to hold a significant share in global revenue owing to the adoption of advanced technologies and the availability of improved healthcare infrastructure, and also rise in R&D laboratories resultant.